|Bid||5.03 x 900|
|Ask||5.04 x 800|
|Day's range||4.82 - 5.33|
|52-week range||1.05 - 11.59|
|Beta (5Y monthly)||1.35|
|PE ratio (TTM)||N/A|
|Earnings date||09 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||11.35|
The average of price targets set by Wall Street analysts indicates a potential upside of 105.6% in Avadel (AVDL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Investors who take an interest in Avadel Pharmaceuticals plc ( NASDAQ:AVDL ) should definitely note that the Senior VP...
The big shareholder groups in Avadel Pharmaceuticals plc ( NASDAQ:AVDL ) have power over the company. Generally...